Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.75 |
| ▸ | PI4KA | P42356 | 2/20 | 0.75 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.75 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.75 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.75 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.75 |
| ▸ | DPP4 | P27487 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.75 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.75 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.75 |
| ▸ | GAPDH | P04406 | 1/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.75 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.75 |
| ▸ | STAT6 | P42226 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.75 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3417640 | 1.00 | ADORA3 (0.75) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL8888273 | 0.92 | ADORA3 (0.72) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL8888270 | 0.92 | ADORA3 (0.72) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL8888538 | 0.92 | ADORA3 (0.72) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL23813581 | 0.91 | ADORA3 (0.82) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL17198348 | 0.91 | ADORA3 (0.82) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9140587 | 0.91 | ADORA3 (0.70) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9146345 | 0.91 | ADORA3 (0.70) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9146357 | 0.91 | ADORA3 (0.70) | ADORA3PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9140578 | 0.91 | ADORA3 (0.70) | ADORA3PI4KAPI4K2BPI4K2API4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128741-A1 | OCTADECANOID COMPOSITIONS AND METHODS OF ACTIVATING MUCOSAL REPAIR PATHWAYS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-114836399-B | Process for preparing isoguanine deoxyribonucleotide | 天津大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-118001425-A | Preparation method and application of nanoparticle capable of targeting brain injury part for traumatic brain injury treatment | 上海市第六人民医院 | 2024-05-10 | — | — | CN | disclosed |
| US-11959065-B2 | Bacillus megaterium bioactive compositions and metabolites | PRO FARM GROUP, INC. (US) | 2024-04-16 | — | — | US | disclosed |
| US-20230142126-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES | HEALION BIO., INC. (US) | 2023-05-11 | — | — | US | disclosed |
| EP-4149552-A1 | COMPOSITIONS AND METHODS FOR INCREASING EFFICACY OF A DRUG | Healion Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| US-20220315885-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | MARRONE BIO INNOVATIONS, INC. (US) | 2022-10-06 | — | — | US | disclosed |
| CN-114836399-A | Preparation method of isoguanine deoxyribonucleotide | 天津大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-114836400-A | Enzyme participating in synthesis of bacteriophage diaminopurine and application thereof | 天津大学 | 2022-08-02 | — | — | CN | disclosed |
| WO-2022152192-A1 | ENZYME INVOLVED IN PHAGE DIAMINOPURINE SYNTHESIS, AND USE THEREOF | 天津大学 | 2022-07-21 | — | — | WO | disclosed |
| US-7351827-B2 | Substituted oxetanes, method of making, and method of use thereof | THE UNIVERSITY OF CONNECTICUT (US) | 2008-04-01 | — | — | US | disclosed |
| US-7214668-B2 | Phosphonic acid based prodrugs of PMEA and its analogues | METABASIS THERAPEUTICS, INC. (US) | 2007-05-08 | — | — | US | disclosed |
| EP-1532157-A2 | NOVEL PHOSPHONIC ACID BASED PRODRUGS OF PMEA AND ITS ANALOGUES | Metabasis Therapeutics, Inc. (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004037161-A2 | CYCLIC PRODRUGS OF PMEA ONE OF ITS ANALOGUES | METABASIS THERAPEUTICS, INC. (US) | 2004-05-06 | — | — | WO | disclosed |
| US-20030229225-A1 | Novel phosphonic acid based prodrugs of PMEA and its analogues | METABASIS THERAPEUTICS, INC. | 2003-12-11 | — | — | US | disclosed |
| US-5597824-A | VIRICIDES | ABBOTT LABORATORIES (US) | 1997-01-28 | — | — | US | disclosed |
| US-5420276-A | Ring contraction via diazoketone intermediate, active against herpes | ABBOTT LABORATORIES (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0292588-B1 | NOVEL COMPOUND HAVING HYPOXANTHINE BASE,ITS USE AND PROCESS FOR PRODUCING IT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-04-01 | — | — | EP | disclosed |
| EP-0433898-A2 | Analogs of oxetanyl purines and pyrimidines | ABBOTT LABORATORIES (US) | 1991-06-26 | — | — | EP | disclosed |
| US-4845215-A | VIRICIDE, IMMUNOSUPPRESANT | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142126-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL DISEASES | CTSV, CTSB, CTSS | ADORA3 3416/4885PI4KA 2121/4885PI4K2B 2189/4885 |
| US-20030229225-A1 | Novel phosphonic acid based prodrugs of PMEA and its analogues | MTAP, PNP, MPO | ADORA3 115/4885PI4KA 811/4885PI4K2B 714/4885 |
| US-11959065-B2 | Bacillus megaterium bioactive compositions and metabolites | GZMB, VIP, BAX | ADORA3 4282/4885PI4KA 1375/4885PI4K2B 587/4885 |
| US-20220315885-A1 | BACILLUS MEGATERIUM BIOACTIVE COMPOSITIONS AND METABOLITES | GZMB, VIP, BAX | ADORA3 4282/4885PI4KA 1375/4885PI4K2B 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.